Mauritius vs Tajikistan: Women's share of population ages 15+ living with HIV
Mauritius
37.4%
in 2024
Tajikistan
36.8%
in 2024
Mauritius rank
78th
Tajikistan rank
80th
Women's share of population ages 15+ living with HIV over time
- Mauritius
- Tajikistan
How they compare
Mauritius currently reports 37.4% against 36.8% in Tajikistan, a difference of 0.6%.
The two have swapped places 2 times across 35 shared years of data; in 1990 it was Mauritius ahead.
Mauritius ranks 78th and Tajikistan ranks 80th of 172 countries.
Across the 4 decades both report, Mauritius averaged higher in 1 and Tajikistan in 3.
Head to head by decade
| Decade | Mauritius | Tajikistan | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 58.9% | 31.6% | 27.3% | Mauritius |
| 2000s | 31.6% | 36.9% | 5.2% | Tajikistan |
| 2010s | 31.8% | 35.0% | 3.3% | Tajikistan |
| 2020s | 35.7% | 36.2% | 0.5% | Tajikistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher women's share of population ages 15+ living with hiv, Mauritius or Tajikistan?
- Mauritius, at 37.4% against 36.8% in Tajikistan as of 2024.
- What is the difference in women's share of population ages 15+ living with hiv between Mauritius and Tajikistan?
- 0.6%, with Mauritius ahead.
- How many years of comparable data are there for Mauritius and Tajikistan?
- 35 years are reported by both, from 1990 to 2024.
- How do Mauritius and Tajikistan rank globally for women's share of population ages 15+ living with hiv?
- Mauritius ranks 78th and Tajikistan ranks 80th of 172 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Women's share of population ages 15+ living with HIV (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Prevalence of HIV is the percentage of people who are infected with HIV. Female rate is as a percentage of the total population ages 15+ who are living with HIV.